44
Participants
Start Date
December 1, 2025
Primary Completion Date
December 1, 2028
Study Completion Date
June 30, 2029
Ketamine hydrochloride
Participants in Arms 1, 2, and 3 will receive four twice-weekly ketamine hydrochloride intravenous infusions dosed at 0.5mg/kg.
Minimally Enhanced Usual Care
Minimally Enhanced Usual Care will consist of educational reading materials regarding chronic back pain and depression and will be provided to participants in arms 2 and 3 (pilot RCT).
Brief narrative intervention
"Participants in Arm 1 (open label pilot) will receive the brief narrative intervention after four ketamine infusions.~Participants in Arm 2 (those randomized after ketamine infusions are complete to the active arm of the pilot RCT) will receive the brief narrative intervention."
VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
VA Office of Research and Development
FED